NYSE · EVH
Healthcare · Medical - Healthcare Information Services
$3.69
Up+$0.00 (+0.00%)
Updated Sep 22, 2026, 8:06 AM
SID Score
4.2/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 20 trading sessions · Daily adjusted prices
EVH closed at $3.69 after 20 trading sessions, down 21.82% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 21, 2026 | $3.70 | $3.745 | $3.58 | $3.69 | 2M |
| Sep 18, 2026 | $3.65 | $3.725 | $3.625 | $3.69 | 2.56M |
| Sep 17, 2026 | $3.74 | $3.79 | $3.635 | $3.67 | 4.2M |
| Sep 16, 2026 | $3.835 | $3.835 | $3.715 | $3.74 | 1.4M |
| Sep 15, 2026 | $4.12 | $4.125 | $3.71 | $3.74 | 5.31M |
| Sep 14, 2026 | $4.18 | $4.24 | $4.05 | $4.10 | 3.49M |
| Sep 11, 2026 | $4.19 | $4.23 | $4.10 | $4.19 | 1.7M |
| Sep 10, 2026 | $4.12 | $4.245 | $4.06 | $4.17 | 1.64M |
| Sep 9, 2026 | $4.24 | $4.315 | $4.055 | $4.15 | 1.86M |
| Sep 8, 2026 | $4.26 | $4.345 | $4.055 | $4.22 | 2.38M |
| Sep 4, 2026 | $4.23 | $4.345 | $4.15 | $4.32 | 1.73M |
| Sep 3, 2026 | $4.21 | $4.28 | $4.065 | $4.26 | 1.79M |
| Sep 2, 2026 | $4.28 | $4.41 | $4.21 | $4.23 | 1.5M |
| Sep 1, 2026 | $4.45 | $4.51 | $4.215 | $4.28 | 2.83M |
| Aug 31, 2026 | $4.51 | $4.535 | $4.305 | $4.50 | 2.53M |
| Aug 28, 2026 | $4.54 | $4.74 | $4.43 | $4.60 | 2.21M |
| Aug 27, 2026 | $4.93 | $4.93 | $4.56 | $4.59 | 2.92M |
| Aug 26, 2026 | $4.80 | $5.03 | $4.735 | $4.92 | 2.23M |
| Aug 25, 2026 | $4.72 | $4.955 | $4.595 | $4.89 | 2.87M |
| Aug 24, 2026 | $4.67 | $4.79 | $4.55 | $4.72 | 2.06M |
The latest Smart Investors Daily articles mentioning EVH.
EVH research
Company profile and research snapshot.
Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The primary solutions provided by the company include specialty care management services, total cost of care management, and administrative services.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 18, 2026 | JP Morgan | Overweight | — |
| Aug 17, 2026 | TD Cowen | Buy | — |
| Aug 12, 2026 | Truist Securities | Hold | — |
| Aug 11, 2026 | Citigroup | Buy | — |
| Aug 10, 2026 | Canaccord Genuity | Buy | — |
No generated briefing is available yet.
Yahoo · Sep 1, 2026
Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are usually cheap for a reason, and a low valuation can reflect underlying business challenges rather than a genuine bargain.
Benzinga · Aug 18, 2026
JP Morgan analyst John Stansel maintains Evolent Health (NYSE:EVH) with a Overweight and raises the price target from $5 to $6.
Benzinga · Aug 17, 2026
TD Cowen analyst Charles Rhyee maintains Evolent Health (NYSE:EVH) with a Buy and raises the price target from $5 to $6.
Yahoo · Aug 16, 2026
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have returned 26.1% over the past six months, topping the S&P 500 by 13.1 percentage points.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning EVH.
